Abstract:Uterine leiomyomas, the most common tumors of the female reproductive system, are known to have a hypoxic microenvironment. However, the role of such environment in leiomyoma pathobiology remains unknown. The objective was to determine the effects of hypoxia on leiomyoma cells, and the mechanisms. We found that hypoxia induces proliferation and inhibits apoptosis in human leiomyoma cells. This pro-proliferative effect was accompanied by an increase in reactive oxygen species (ROS) generation and the expression of NADPH oxidase 4 (NOX4). The specific NOX4 inhibitor GLX351322 abrogated this hypoxia-induced ROS generation, cellular proliferation, and apoptosis inhibition. To further investigate the mechanism of NOX4-mediated proliferation, we treated leiomyoma cells grown in normoxia with media from leiomyoma cells cultured under hypoxia. This resulted in increased ROS generation and NOX4 expression, suggesting the hypoxia-induced effects are mediated by an autocrine mechanism. We worked to identify the nature of this autocrine factor. We found that the expression of TGF-β3 and its downstream signaling target pSmad3, are increased in hypoxic leiomyoma cells. To examine the hypothesis that TGF-β3 is, at least, a part of this autocrine mechanism, we treated hypoxic leiomyoma cells with the HIF-1α inhibitor KC7F2 which we discovered to ameliorate the hypoxia-induced TGF-β3 expression. Furthermore, pharmacologic inhibition with the TGF-β/Smad inhibitor SB431542 reduced hypoxia-induced NOX4 expression and ROS generation and attenuated cell proliferation. Thus, we have identified a novel mechanism by which hypoxia induces proliferation in leiomyoma cells. This finding adds to our understanding of leiomyoma pathobiology and can help in identifying new therapeutic targets.Graphical A cartoon illustrating the mechanism by which hypoxia induces NOX4-mediated leiomyoma cell proliferation via ROS generation and TGF-β3 pathway. HIF-1α, hypoxia inducible factor 1 alpha; TGF-β3, transforming growth factor beta 3; TGFβR, transforming growth factor beta receptor; NOX4, nicotinamide adenine dinucleotide phosphate (NADPH) oxidase 4; ROS, reactive oxygen species. A cartoon illustrating the mechanism by which hypoxia induces NOX4-mediated leiomyoma cell proliferation via ROS generation and TGF-β3 pathway. HIF-1α, hypoxia inducible factor 1 alpha; TGF-β3, transforming growth factor beta 3; TGFβR, transforming growth factor beta receptor; NOX4, nicotinamide adenine dinucleotide phosphate (NADPH) oxidase 4; ROS, reactive oxygen species.

Inactivation of AKT induces cellular senescence in uterine leiomyoma.

Estrogen Regulates MAPK-Related Genes through Genomic and Nongenomic Interactions between IGF-I Receptor Tyrosine Kinase and Estrogen Receptor-Alpha Signaling Pathways in Human Uterine Leiomyoma Cells

DOWNREGULATION OF SIRT3 CONTRIBUTES TO UTERINE FIBROID PHENOTYPE, WHICH IS INHIBITED BY NATURAL SIRT3 ACTIVATOR HONOKIOL

Clinical and Expression Significance of AKT1 by Co-expression Network Analysis in Endometrial Cancer.

Growth and Activation of PI-3K/PKB and Akt by Stromal Cell-Derived Factor 1α in Endometrial Carcinoma Cells with Expression of Suppressor Endoprotein PTEN

Astragaloside IV Inhibits the Proliferation of Human Uterine Leiomyomas by Targeting IDO1

Research progress on the PI3K/AKT signaling pathway in gynecological cancer

Inhibition of AKT Suppresses the Initiation and Progression of BRCA1-associated Mammary Tumors.

Regulatory Roles of NAMPT and NAD + Metabolism in Uterine Leiomyoma Progression: Implications for ECM Accumulation, Stemness, and Microenvironment

The Role of Cell Proliferation and Extracellular Matrix Accumulation Induced by Food Additive Butylated Hydroxytoluene in Uterine Leiomyoma

Inhibitor PF-04691502 works as a senolytic to regulate cellular senescence

Sodium tanshinone IIA sulfonate restrains fibrogenesis through induction of senescence in mice with induced deep endometriosis

A gain of function mutation in AKT1 increases hexokinase 2 and diminishes oxidative stress in meningioma

Sunitinib induces cellular senescence via p53/Dec1 activation in renal cell carcinoma cells.

miR-335-5p Inhibits Progression of Uterine Leiomyoma by Targeting ARGLU1

Decreased expression of IDH1 by chronic unpredictable stress suppresses proliferation and accelerates senescence of granulosa cells through ROS activated MAPK signaling pathways

Hypoxia induces proliferation via NOX4-Mediated oxidative stress and TGF-β3 signaling in uterine leiomyoma cells

Paracrine Pathways in Uterine Leiomyoma Stem Cells Involve Insulinlike Growth Factor 2 and Insulin Receptor A

Spatially restricted ecto-5'-nucleotidase expression promotes the growth of uterine leiomyomas by modulating Akt activity

Effects of Fibronectin 1 on Cell Proliferation, Senescence and Apoptosis of Human Glioma Cells Through the PI3K/AKT Signaling Pathway

Plasminogen activator inhibitor 1 - insulin-like growth factor binding protein 3 cascade regulates stress-induced senescence